Peptide Profile N-Acetyl Selank Acetylated tuftsin analogue heptapeptide with enhanced stability and anxiolytic, nootropic, and immunomodulatory properties acting through GABAergic modulation and BDNF upregulation Compound Profile Scientific & Efficacy Data C 35 H 59 N 11 O 10 Molecular Formula 793.9 g/mol Molecular Weight Extended compared to native Selank (~7-10 min plasma half-life)
Although many products claim to contain beneficial peptides, not all are created equal
Bacteriostatic water extends peptide shelf life significantly
GHK-Cus tissue repair profile does support connective tissue healing, tendon and ligament structure, and the anti-inflammatory environment that acute and chronic injury recovery requires
The appropriate framing for every outcome discussed above is observed in research models or preclinical/experimental, never demonstrated in humans. Limitations of the Injectable/Systemic GHK-Cu Evidence Several specific limitations constrain what can be concluded, and they compound one another
Unlike GLP-1 agonists that reduce appetite or growth hormone peptides that stimulate lipolysis, the compound addresses fat metabolism at the enzymatic level: it removes the molecular governor that locks adipocytes into a low-energy-expenditure state, potentially restoring normal metabolic function in fat tissue where NNMT is overexpressed
